Is APTX or RYLD a better dividend investment in 2026?

APTX currently yields 2083.33% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: APTX offers higher current income.

What is the dividend yield difference between APTX and RYLD?

APTX has a forward dividend yield of 2083.33% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 2071.19 percentage points.

Home › Compare › APTX vs RYLD

APTX vs RYLD: Dividend Comparison 2026

APTX yields 2083.33% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 APTX wins by $14544499705.94M in total portfolio value

INVESTMENT

TIME HORIZON10 years

APTX

● Live price

2083.33%

Share price

$0.10

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$14544499705.99M

Annual income

$13,289,647,770,778,488.00

Full APTX calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — APTX vs RYLD

📍 APTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	APTX	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, APTX + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

APTX pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

APTX

Annual income on $10K today (after 15% tax)

$177,083.33/yr

After 10yr DRIP, annual income (after tax)

$11,296,200,605,161,714.00/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, APTX beats the other by $11,296,200,605,159,514.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of APTX + RYLD for your $10,000?

APTX: 50%RYLD: 50%

100% RYLD50/50100% APTX

Portfolio after 10yr

$7272249853.02M

Annual income

$6,644,823,885,390,538.00/yr

Blended yield

91.37%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on APTX right now

APTX

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$1.00

+941.7% upside vs current

Range: $1.00 — $1.00

Altman Z

-14.5

Piotroski

1/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

APTX buys

RYLD buys

No recent congressional trades found for APTX or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAPTXRYLD

Forward yield	2083.33% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$14544499705.99M ✓	$44.5K
Annual income after 10y	$13,289,647,770,778,488.00 ✓	$2,587.35
Total dividends collected	$14455710543.57M ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: APTX vs RYLD ($10,000, DRIP)

Year	APTX Portfolio	APTX Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$219,033	$208,333.33	$11,914	$1,213.65	+$207.1K → APTX
2	$4,499,033	$4,264,667.71	$14,099	$1,351.30	+$4.48M → APTX
3	$86,681,257	$81,867,291.39	$16,580	$1,494.55	+$86.66M → APTX
4	$1,566,868,240	$1,474,119,294.47	$19,384	$1,642.61	+$1566.85M → APTX
5	$26,579,804,805	$24,903,255,789.01	$22,535	$1,794.70	+$26579.78M → APTX
6	$423,253,588,633	$394,813,197,491.25	$26,063	$1,950.00	+$423253.56M → APTX
7	$6,328,542,537,504	$5,875,661,197,666.76	$29,995	$2,107.69	+$6328542.51M → APTX
8	$88,877,753,676,302	$82,106,213,161,172.67	$34,361	$2,266.99	+$88877753.64M → APTX
9	$1,172,758,817,952,321	$1,077,659,621,518,678.10	$39,194	$2,427.12	+$1172758817.91M → APTX
10	$14,544,499,705,987,470	$13,289,647,770,778,488.00	$44,525	$2,587.35	+$14544499705.94M → APTX

APTX vs RYLD: Complete Analysis 2026

APTX — Stock

Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic peripheral neuropathy, as well as in Phase II/b clinical trial for treating fibromyalgia. It is also developing NYX-783, an N-methyl-D-aspartate receptors (NMDAr) modulator that is in Phase II/b clinical trial to treat post-traumatic stress disorder; and NYX-458, an NMDAr modulator, which is in Phase II clinical study for the treatment of Parkinson's disease cognitive impairment. The company has a research collaboration agreement with Allergan plc. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois.

Full APTX Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this APTX vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

APTX vs SCHD APTX vs JEPI APTX vs O APTX vs KO APTX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.